Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $2.5 million.

  • Nephros' Total Current Liabilities rose 13317.58% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 13317.58%. This contributed to the annual value of $1.6 million for FY2024, which is 2607.67% down from last year.
  • Per Nephros' latest filing, its Total Current Liabilities stood at $2.5 million for Q3 2025, which was up 13317.58% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, Nephros' Total Current Liabilities registered a high of $2.5 million during Q3 2025, and its lowest value of $1.1 million during Q3 2024.
  • In the last 5 years, Nephros' Total Current Liabilities had a median value of $1.8 million in 2025 and averaged $1.8 million.
  • As far as peak fluctuations go, Nephros' Total Current Liabilities plummeted by 5469.76% in 2021, and later surged by 13317.58% in 2025.
  • Nephros' Total Current Liabilities (Quarter) stood at $2.4 million in 2021, then plummeted by 40.92% to $1.4 million in 2022, then surged by 49.65% to $2.1 million in 2023, then decreased by 26.08% to $1.6 million in 2024, then surged by 57.94% to $2.5 million in 2025.
  • Its last three reported values are $2.5 million in Q3 2025, $1.8 million for Q2 2025, and $1.5 million during Q1 2025.